NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
MacroGenics
AstraZeneca
Hoffmann-La Roche
Incyte Corporation
NRG Oncology
Hutchmed
Seagen Inc.
Alliance for Clinical Trials in Oncology
Sellas Life Sciences Group
Cancer Research and Biostatistics Clinical Trials Consortium
Exelixis
Massachusetts General Hospital
Rutgers, The State University of New Jersey
Incyte Corporation
Novartis
Gilead Sciences
Incyte Corporation
Institut Bergonié
Advanced Accelerator Applications
Incyte Corporation
Pfizer
University of Kansas Medical Center
Roswell Park Cancer Institute
Fox Chase Cancer Center
INSYS Therapeutics Inc